WHO ICTRP trial

Clinical study on Zandu Chyavanprash as a preventive remedy in pandemic of…

CTRI/2021/01/030454 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2021/01/030454
Public title Clinical study on Zandu Chyavanprash as a preventive remedy in pandemic of Covid-19.
Scientific title Clinical evaluation of Zandu Chyavanprash as an immunity booster for its preventive effect on infections in pandemic of COVID-19 â?? An open label, Multi centric, Randomized, Comparative, Prospective, Interventional Community based Clinical Study on Healthy individuals - NIL
Primary sponsor Emami Ltd
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2/ Phase 3
Countries India
Interventions Intervention1: Zandu Chyavanprash and Milk: Zandu Chyavanprash contains Bilva, Agnimantha, Syonaka, Patala, Gambhari, Shalaprani, Prishniparni , Brihati, Kantakari, Gokshura, Bala, Mudgaparni, Mashaparni, Karkatshringi, Tamalaki, Draksha…
Registration date Jan 14, 2021
Target size 300
Secondary IDs ZCP-CVD-19/2020/01 Version 1.0 Dated 20th Dec 2020
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations